An Overview of the Pharmacodynamic Properties and Therapeutic Potential of Combined α- and β-Adrenoceptor Antagonists
- 1 April 1993
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 45 (4) , 509-517
- https://doi.org/10.2165/00003495-199345040-00003
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Carvedilol and the kidney.1992
- A Comparison of Carvedilol with Atenolol in the Treatment of Mild-to-Moderate Essential HypertensionJournal of Cardiovascular Pharmacology, 1992
- The α‐ and β‐adrenoceptor blocking activities of labetalol and its RR‐SR (50:50) stereoisomersBritish Journal of Pharmacology, 1991
- Clinical efficacy of carvedilol in severe hypertension.1991
- Effects of carvedilol on serum lipids in patients with essential hypertension.1991
- Carvedilol (Kredex®) Reduces Infarct Size in a Canine Model of Acute Myocardial InfarctionPharmacology, 1991
- LabetalolDrugs, 1989
- DoxazosinDrugs, 1988
- Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties.British Journal of Clinical Pharmacology, 1984
- Effects of the new beta-adrenoceptor blocking agent, S-596 on the peripheral autonomic nervous system and smooth muscles.1983